ATE401889T1 - Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien - Google Patents

Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien

Info

Publication number
ATE401889T1
ATE401889T1 AT05734016T AT05734016T ATE401889T1 AT E401889 T1 ATE401889 T1 AT E401889T1 AT 05734016 T AT05734016 T AT 05734016T AT 05734016 T AT05734016 T AT 05734016T AT E401889 T1 ATE401889 T1 AT E401889T1
Authority
AT
Austria
Prior art keywords
mmp
sub
prevention
treatment
inflammatory diseases
Prior art date
Application number
AT05734016T
Other languages
English (en)
Inventor
Didier Cataldo
Luc Delattre
Brigitte Evrard
Jean-Michel Foidart
Hans-Willi Krell
Original Assignee
Hoffmann La Roche
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Univ Liege filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE401889T1 publication Critical patent/ATE401889T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT05734016T 2004-04-01 2005-03-31 Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien ATE401889T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04007920 2004-04-01

Publications (1)

Publication Number Publication Date
ATE401889T1 true ATE401889T1 (de) 2008-08-15

Family

ID=34924546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734016T ATE401889T1 (de) 2004-04-01 2005-03-31 Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien

Country Status (13)

Country Link
US (1) US20070225253A1 (de)
EP (1) EP1737464B1 (de)
JP (1) JP4584981B2 (de)
CN (1) CN100558362C (de)
AT (1) ATE401889T1 (de)
AU (1) AU2005230379B2 (de)
BR (1) BRPI0509562A (de)
CA (1) CA2561828C (de)
DE (1) DE602005008418D1 (de)
ES (1) ES2311220T3 (de)
MX (1) MXPA06011030A (de)
RU (1) RU2402329C2 (de)
WO (1) WO2005097133A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548624A1 (de) * 1995-12-23 1997-06-26 Boehringer Mannheim Gmbh Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ES2247707T3 (es) * 1997-06-21 2006-03-01 Roche Diagnostics Gmbh Derivados del acido barbiturico con actividad antimetastasica y antitumoral.
DE19726427A1 (de) * 1997-06-23 1998-12-24 Boehringer Mannheim Gmbh Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FI990888A0 (fi) * 1999-04-20 1999-04-20 Medix Biochemica Ab Oy Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
CO5210860A1 (es) * 1999-10-01 2002-10-30 Hoffmann La Roche Nuevos derivados de pirimidina-2,4,6-triona
AP2001002318A0 (en) * 2000-10-26 2001-12-31 Pfizer Prod Inc Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
MXPA03003734A (es) * 2000-10-26 2003-07-28 Pfizer Prod Inc Inhibifores de metaloproteinasa del tipo pirimidin-2, 4, 6-triona.

Also Published As

Publication number Publication date
DE602005008418D1 (de) 2008-09-04
AU2005230379B2 (en) 2010-07-22
BRPI0509562A (pt) 2007-09-25
CN100558362C (zh) 2009-11-11
US20070225253A1 (en) 2007-09-27
CA2561828A1 (en) 2005-10-20
WO2005097133A1 (en) 2005-10-20
JP4584981B2 (ja) 2010-11-24
CN1950087A (zh) 2007-04-18
RU2402329C2 (ru) 2010-10-27
MXPA06011030A (es) 2007-03-21
CA2561828C (en) 2012-05-22
EP1737464A1 (de) 2007-01-03
RU2006138430A (ru) 2008-06-10
JP2007530625A (ja) 2007-11-01
EP1737464B1 (de) 2008-07-23
ES2311220T3 (es) 2009-02-01
AU2005230379A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
ATE548354T1 (de) Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen
ATE353880T1 (de) Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate
ATE456955T1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
NO20070526L (no) Kinazolindionderivater som parp-inhibitorer
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
WO2003009855A3 (de) Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
DE60026155D1 (de) Einige alkylendiamin-substituierte heterocyclen
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
TW200700422A (en) Compounds for inhibiting ksp kinesin activity
ECSP055844A (es) Nuevos compuestos triciclicos
WO2006028963A3 (en) Substituted heterocyclic compounds and uses thereof
NO20054494L (no) Peptidvektorer
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
DK1532124T3 (da) Anvendelse af nitriderivater som medikament
WO2006002763A3 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
DE60329326D1 (de) Tace inhibitoren
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
ATE401889T1 (de) Verwendung von trioxopyrimidin zur behandlung und prävention von entzündlichen erkrankungen der bronchien
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1737464

Country of ref document: EP

EEIH Change in the person of patent owner